Okada S, Okazaki N
Dept. of Internal Medicine, National Cancer Center Hospital, Japan.
Gan To Kagaku Ryoho. 1991 Jul;18(8):1269-72.
Chemotherapy for cancers of the biliary tract remains underdeveloped, mainly because of their low incidence. There have been no well-designed chemotherapeutic trials based on a sufficient number of cases in this field. The summarized results from the literature and our experience indicate no standard regimen for chemotherapy of the biliary tract cancers. To improve chemotherapy for these cancers, the development of new active anticancer agents is essential. And, for clinical trials of chemotherapy for this relatively rare cancer, a cooperative group study is considered to be necessary to obtain meaningful results within a reasonable period.
胆道癌的化疗仍未充分发展，主要原因是其发病率较低。该领域尚无基于足够病例数的精心设计的化疗试验。文献总结结果及我们的经验表明，目前尚无胆道癌化疗的标准方案。为改善这些癌症的化疗效果，开发新的有效抗癌药物至关重要。而且，对于这种相对罕见癌症的化疗临床试验，合作组研究被认为是在合理时间内获得有意义结果所必需的。
